These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23783026)

  • 1. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
    Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
    Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of E-cadherin, β-catenin, and S100A4 in intestinal type and nonintestinal type ampulla of Vater cancers.
    Sung R; Kang L; Han JH; Choi JW; Lee SH; Lee TH; Park SH; Kim HJ; Lee ES; Kim YS; Choi YW; Park SM
    Gut Liver; 2014 Jan; 8(1):94-101. PubMed ID: 24516707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.
    Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G
    Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.
    Kimura K; Endo Y; Yonemura Y; Heizmann CW; Schafer BW; Watanabe Y; Sasaki T
    Int J Oncol; 2000 Jun; 16(6):1125-31. PubMed ID: 10811984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
    Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
    Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
    Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
    Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
    Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.
    Oida Y; Yamazaki H; Tobita K; Mukai M; Ohtani Y; Miyazaki N; Abe Y; Imaizumi T; Makuuchi H; Ueyama Y; Nakamura M
    Oncol Rep; 2006 Sep; 16(3):457-63. PubMed ID: 16865243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A4 regulates E-cadherin expression in oral squamous cell carcinoma.
    Moriyama-Kita M; Endo Y; Yonemura Y; Heizmann CW; Miyamori H; Sato H; Yamamoto E; Sasaki T
    Cancer Lett; 2005 Dec; 230(2):211-8. PubMed ID: 16297707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer.
    Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS
    J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
    Pedersen KB; Nesland JM; Fodstad Ø; Maelandsmo GM
    Br J Cancer; 2002 Nov; 87(11):1281-6. PubMed ID: 12439718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
    Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
    World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
    Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
    J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.